| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Scopus BioPharma Inc (NASDAQ: SCPS)
SCPS Technical Analysis
5
| As on 9th Jun 2023 SCPS STOCK Price closed @ 0.06 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.60 & Strong Sell for SHORT-TERM with Stoploss of 1.20 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SCPSSTOCK Price
| Open | 0.06 | Change | Price | % |
| High | 0.06 | 1 Day | 0.01 | 20.00 |
| Low | 0.06 | 1 Week | 0.01 | 20.00 |
| Close | 0.06 | 1 Month | 0.01 | 20.00 |
| Volume | 310 | 1 Year | -1.98 | -97.06 |
| 52 Week High 2.06 | 52 Week Low 0.05 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SCPS Daily Charts |
SCPS Intraday Charts |
Whats New @ Bazaartrend |
SCPS Free Analysis |
|
|
SCPS Important Levels Intraday
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
SCPS Forecast May 2024
| 4th UP Forecast | 1.66 |
| 3rd UP Forecast | 1.15 |
| 2nd UP Forecast | 0.83 |
| 1st UP Forecast | 0.51 |
| 1st DOWN Forecast | -0.39 |
| 2nd DOWN Forecast | -0.71 |
| 3rd DOWN Forecast | -1.03 |
| 4th DOWN Forecast | -1.54 |
SCPS Weekly Forecast
| 4th UP Forecast | 0.85 |
| 3rd UP Forecast | 0.60 |
| 2nd UP Forecast | 0.44 |
| 1st UP Forecast | 0.28 |
| 1st DOWN Forecast | -0.16 |
| 2nd DOWN Forecast | -0.32 |
| 3rd DOWN Forecast | -0.48 |
| 4th DOWN Forecast | -0.73 |
SCPS Forecast2024
| 4th UP Forecast | 4.05 |
| 3rd UP Forecast | 2.77 |
| 2nd UP Forecast | 1.98 |
| 1st UP Forecast | 1.19 |
| 1st DOWN Forecast | -1.07 |
| 2nd DOWN Forecast | -1.86 |
| 3rd DOWN Forecast | -2.65 |
| 4th DOWN Forecast | -3.93 |
Scopus BioPharma Inc ( NASDAQ USA Symbol : SCPS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SCPS Business Profile
Scopus BioPharma Inc., a biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. Its lead development programs are immuno-oncology gene therapy for the treatment of various cancers, which include CO-sTiRNA, a STAT3 inhibitor gene therapy that drives tumor cell growth and anti-tumor immune suppression; and MRI-1867, a cannabinoid-1 receptor inverse agonist and inhibitor of inducible nitric oxide synthase for the treatment of systemic sclerosis. Scopus BioPharma Inc. has strategic partnerships with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem for its lead development and other programs. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York. Address: 420 Lexington Avenue, New York, NY, United States, 10170
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service